Literature DB >> 33858370

Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics.

Łukasz Boguszewicz1, Agata Bieleń2, Jarosław Dawid Jarczewski3, Mateusz Ciszek4, Agnieszka Skorupa4, Krzysztof Składowski2, Maria Sokół4.   

Abstract

BACKGROUND: The aim of this prospective study is to identify the biomarkers associated with the effects of induction chemotherapy (iCHT) in terms of the favorable/weaker response to the treatment in locally advanced head and neck squamous cells carcinomas (LA-HNSCC).
METHODS: The studied group consisted of 53 LA-HNSCC patients treated with iCHT. The treatment tolerance was measured by the Common Terminology Criteria for Adverse Events (CTCAE). The response to the treatment was evaluated by the clinical, fiberoptic and radiological examinations made before and after iCHT (the TNM Classification of Malignant Tumors was used for classifying the extent of cancer spread). Proton nuclear magnetic resonance (1H NMR) serum spectra of the samples collected before and after iCHT were acquired with a 400 MHz spectrometer and analyzed using the multivariate and univariate statistical methods.
RESULTS: The molecular response to iCHT involves an increase of the serum lipids which is accompanied by the simultaneous decrease of alanine, glucose and N-acetyl-glycoprotein (NAG). Furthermore, in males, the iCHT induced changes in the lipid signals and NAG significantly correlate with the regression of the primary tumor. The OPLS-DA multivariate model identified two subgroups of the patients with a weaker metabolic and clinical response. The first one consisted of the patients with a significantly lower initial nodal stage, the second one showed no differences in the initial clinical and metabolic statuses.
CONCLUSIONS: The NMR-based metabolomic study of the serum spectra revealed that iCHT induces the marked changes in the LA-HNSCC patients' metabolic profiles and makes it possible to stratify the patients according to their response to iCHT. These effects are sex dependent. Further studies on a larger scale accounting for sex and the clinical and metabolic factors are warranted.

Entities:  

Keywords:  Chemotherapy; Head and neck; Metabolomics; NMR; Treatment outcome

Year:  2021        PMID: 33858370     DOI: 10.1186/s12885-021-08137-4

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  33 in total

1.  Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck.

Authors:  Andreas E Albers; Regina Grabow; Xu Qian; Masen D Jumah; Veit M Hofmann; Alexander Krannich; Gabriele Pecher
Journal:  Mol Clin Oncol       Date:  2017-06-01

2.  Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Authors:  Jan B Vermorken; Eva Remenar; Carla van Herpen; Thierry Gorlia; Ricard Mesia; Marian Degardin; John S Stewart; Svetislav Jelic; Jan Betka; Joachim H Preiss; Danielle van den Weyngaert; Ahmad Awada; Didier Cupissol; Heinz R Kienzer; Augustin Rey; Isabelle Desaunois; Jacques Bernier; Jean-Louis Lefebvre
Journal:  N Engl J Med       Date:  2007-10-25       Impact factor: 91.245

3.  Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Authors:  Marshall R Posner; Diane M Hershock; Cesar R Blajman; Elizabeth Mickiewicz; Eric Winquist; Vera Gorbounova; Sergei Tjulandin; Dong M Shin; Kevin Cullen; Thomas J Ervin; Barbara A Murphy; Luis E Raez; Roger B Cohen; Monica Spaulding; Roy B Tishler; Berta Roth; Rosana del Carmen Viroglio; Varagur Venkatesan; Ilya Romanov; Sanjiv Agarwala; K William Harter; Matthew Dugan; Anthony Cmelak; Arnold M Markoe; Paul W Read; Lynn Steinbrenner; A Dimitrios Colevas; Charles M Norris; Robert I Haddad
Journal:  N Engl J Med       Date:  2007-10-25       Impact factor: 91.245

Review 4.  Pharmacogenomics of sex difference in chemotherapeutic toxicity.

Authors:  Jeffrey Wang; Ying Huang
Journal:  Curr Drug Discov Technol       Date:  2007-06

Review 5.  Somatic evolution of head and neck cancer - biological robustness and latent vulnerability.

Authors:  Muneyuki Masuda; Satoshi Toh; Takahiro Wakasaki; Masumi Suzui; Andrew K Joe
Journal:  Mol Oncol       Date:  2012-11-02       Impact factor: 6.603

Review 6.  Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.

Authors:  Remco de Bree; Gregory T Wolf; Bart de Keizer; Iain J Nixon; Dana M Hartl; Arlene A Forastiere; Missak Haigentz; Alessandra Rinaldo; Juan P Rodrigo; Nabil F Saba; Carlos Suárez; Jan B Vermorken; Alfio Ferlito
Journal:  Head Neck       Date:  2017-08-17       Impact factor: 3.147

7.  Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma.

Authors:  Ting Jin; Wei-Feng Qin; Feng Jiang; Qi-Feng Jin; Qi-Chun Wei; Yong-Shi Jia; Xiao-Nan Sun; Wen-Feng Li; Xiao-Zhong Chen
Journal:  Transl Oncol       Date:  2019-02-20       Impact factor: 4.243

8.  Docetaxel in the treatment of squamous cell carcinoma of the head and neck.

Authors:  Alexander Rapidis; Nicholas Sarlis; Jean-Louis Lefebvre; Merrill Kies
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

9.  Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions.

Authors:  R I Haddad; M Posner; R Hitt; E E W Cohen; J Schulten; J-L Lefebvre; J B Vermorken
Journal:  Ann Oncol       Date:  2018-05-01       Impact factor: 32.976

10.  Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study.

Authors:  Danilo Galizia; Andrea Milani; Elena Geuna; Rossella Martinello; Celeste Cagnazzo; Manuela Foresto; Virginia Longo; Paola Berchialla; Gianfranca Solinas; Adele Calori; Bruna Grasso; Chiara Volpone; Gisella Bertola; Gisella Parola; Giancarla Tealdi; Piero Luigi Giuliano; Anna Maria Ballari; Massimo Aglietta; Filippo Montemurro
Journal:  Cancer Med       Date:  2018-07-20       Impact factor: 4.452

View more
  1 in total

Review 1.  Metabolomics and health: from nutritional crops and plant-based pharmaceuticals to profiling of human biofluids.

Authors:  Andrey S Marchev; Liliya V Vasileva; Kristiana M Amirova; Martina S Savova; Zhivka P Balcheva-Sivenova; Milen I Georgiev
Journal:  Cell Mol Life Sci       Date:  2021-08-19       Impact factor: 9.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.